High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer

Genes Chromosomes and Cancer

Volumn 51, Issue 6, 2012, Pages 579-589

  Boyd, Lara K ^a   Mao, Xueying ^a   Xue, Liyan ^a,b   Lin, Dongmei ^a,b   Chaplin, Tracy ^a   Kudahetti, Sakunthala C ^a   Stankiewicz, Elzbieta ^a   Yu, Yongwei ^c   Beltran, Luis ^d   Shaw, Greg ^d   Hines, John ^d   Oliver, R Tim D ^a   Berney, Daniel M ^a   Young, Bryan D ^a   Lu, Yong Jie ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CANCER HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CHROMOSOME 10Q; CHROMOSOME 16Q; CHROMOSOME 21Q; CHROMOSOME 6Q; CHROMOSOME 8P; CLINICAL ARTICLE; COPY NUMBER VARIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HIGH RESOLUTION GENOME WIDE COPY NUMBER ANALYSIS; HISTOPATHOLOGY; HUMAN; MALE; MICROARRAY ANALYSIS; MULTIFOCAL PROSTATE CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

AGED; CLONAL EVOLUTION; GENE DOSAGE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASTIC PROCESSES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84862815211     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21944     Document Type: Article

References (42)

1. Abate-Shen C, Shen MM, Gelmann E. 2008. Integrating differentiation and cancer: The Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Differentiation 76: 717-727.
2. Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L. 2004. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100: 2362-2366.
3. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, Onofrio R, Carter SL, Park K, Habegger L, Ambrogio L, Fennell T, Parkin M, Saksena G, Voet D, Ramos AH, Pugh TJ, Wilkinson J, Fisher S, Winckler W, Mahan S, Ardlie K, Baldwin J, Simons JW, Kitabayashi N, MacDonald TY, Kantoff PW, Chin L, Gabriel SB, Gerstein MB, Golub TR, Meyerson M, Tewari A, Lander ES, Getz G, Rubin MA, Garraway LA. 2011. The genomic complexity of primary human prostate cancer. Nature 470: 214-220.
4. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, Cheng L. 1998. Independent origin of multiple foci of prostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma. Cancer 83: 1995-2002.
5. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB. 1993. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53: 3869-3873.
6. Cheng L, Song SY, Pretlow TG, Abdul-Karim FW, Kung HJ, Dawson DV, Park WS, Moon YW, Tsai ML, Linehan WM, Emmert-Buck MR, Liotta LA, Zhuang Z. 1998. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 90: 233-237.
7. Coombs NJ, Boyages J. 2005. Multifocal and multicentric breast cancer: Does each focus matter? J Clin Oncol 23: 7497-7502.
8. Gaisa NT, Graham TA, McDonald SAC, Poulsom R, Heidenreich A, Jakse G, Knuechel R, Wright NA. 2011. Clonal architecture of human prostatic epithelium in benign and malignant conditions. J Pathol 225: 172-180.
9. Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT. 1991. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146: 1069-1076.
10. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
11. Han B, Mehra R, Lonigro RJ, Wang L, Suleman K, Menon A, Palanisamy N, Tomlins SA, Chinnaiyan AM, Shah RB. 2009. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression. Mod Pathol 22: 1083-1093.
12. Hodges KB, Cummings OW, Saxena R, Wang M, Zhang S, Lopez-Beltran A, Montironi R, Nour H, Cheng L. Clonal origin of multifocal hepatocellular carcinoma. 2010. Cancer 116: 4078-4085.
13. Hugel A, Wernert N. 1999. Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer. Br J Cancer 79: 551-557.
14. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA. 2008. Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68.
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
16. Kallioniemi OP, Visakorpi T. 1996. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 68: 225-255.
17. Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A. 1992. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70: 1585-1590.
18. Kobayashi M, Ishida H, Shindo T, Niwa S, Kino M, Kawamura K, Kamiya N, Imamoto T, Suzuki H, Hirokawa Y, Shiraishi T, Tanizawa T, Nakatani Y, Ichikawa T. 2008. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization. Prostate 68: 1715-1724.
19. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. 2001. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 98: 11563-11568.
20. Liu W, Ewing CM, Chang BL, Li T, Sun J, Turner AR, Dimitrov L, Zhu Y, Kim JW, Zheng SL, Isaacs WB, Xu J. 2007. Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers. Genes Chromosomes Cancer 46: 972-980.
21. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Carducci MA, Nelson WG, Yegnasubramanian S, Luo J, Wang Y, Xu J, Isaacs WB, Visakorpi T, Bova GS. 2009. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15: 559-565.
22. Mao X, James SY, Yanez-Munoz RJ, Chaplin T, Molloy G, Oliver RT, Young BD, Lu YJ. 2007. Rapid high-resolution karyotyping with precise identification of chromosome breakpoints. Genes Chromosomes Cancer 46: 675-683.
23. Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E, Xue L, Beltran L, Gupta M, Oliver RT, Lemoine NR, Berney DM, Young BD, Lu YJ. 2010. Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res 70: 5207-5212.
24. Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ, Shen R, Montie JE, Chinnaiyan AM, Shah RB. 2007. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res 67: 7991-7995.
25. Miller GJ, Cygan JM. 1994. Morphology of prostate cancer: The effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol 152: 1709-1713.
26. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194: 23-28.
27. Paulsson K, Cazier JB, Macdougall F, Stevens J, Stasevich I, Vrcelj N, Chaplin T, Lillington DM, Lister TA, Young BD. 2008. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci USA 105: 6708-6713.
28. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB. 1995a. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55: 5408-5414.
29. Qian J, Jenkins RB, Bostwick DG. 1995b. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Urology 46: 837-842.
30. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. 1996. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 180: 295-299.
31. Ruijter ET, Miller GJ, van de Kaa CA, van Bokhoven A, Bussemakers MJ, Debruyne FM, Ruiter DJ, Schalken JA. 1999. Molecular analysis of multifocal prostate cancer lesions. J Pathol 188: 271-277.
32. Russell WO, Ibanez ML, Clark RL, White EC. 1963. Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 Glands. Cancer 16: 1425-1460.
33. Shattuck TM, Westra WH, Ladenson PW, Arnold A. 2005. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 352: 2406-2412.
34. Stamatiou KN, Dilernia GC, Ilias GK, Daskalopoulos GK, Koutelekos IK, Marianou SN, Sofras FA. 2009. The phenomenon of multifocality does not affect the biologic behavior of histologic prostate carcinoma. Med Sci Monit 15: BR61-BR63.
35. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J. 1995. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromosomes Cancer 13: 168-174.
36. Villers A, McNeal JE, Freiha FS, Stamey TA. 1992. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70: 2313-2318.
37. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM. 1996. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 56: 2411-2416.
38. von Eschenbach AC. 1996. The biologic dilemma of early carcinoma of the prostate. Cancer 78: 326-329.
39. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H. 2003. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
40. Wang X, Wang M, MacLennan GT, Abdul-Karim FW, Eble JN, Jones TD, Olobatuyi F, Eisenberg R, Cummings OW, Zhang S, Lopez-Beltran A, Montironi R, Zheng S, Lin H, Davidson DD, Cheng L. 2009. Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst 101: 560-570.
41. Xin L, Lawson DA, Witte ON. 2005. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102: 6942-6947.
42. Yoshimoto M, Cutz JC, Nuin PA, Joshua AM, Bayani J, Evans AJ, Zielenska M, Squire JA. 2006. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet Cytogenet 169: 128-137.